Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term carcinoma cell-lines. Found 10 abstracts

Sauter ER, Herlyn M, Liu SC, Litwin S, Ridge JA. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model. Clinical Cancer Research. 2000 Feb;6(2):654-60.
Zhang CC, Yang JM, Bash-Babula J, White E, Murphy M, Levine AJ, Hait WN. DNA damage increases sensitivity to Vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4. Cancer Research. 1999 Aug;59(15):3663-70.
Johnson SW, Ferry KV, Hamilton TC. Recent insights into platinum drug resistance in cancer. Drug Resistance Updates. 1998 Jan;1(4):243-54.
Laing N, Dahllof B, HartleyAsp B, Ranganathan S, Tew KD. Interaction of estramustine with tubulin isotypes. Biochemistry. 1997 Jan 28;36(4):871-8.
Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C. Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate-Cancer. Seminars in Oncology. 1995 Oct;22(5):41-5.
Schilder RJ, Lacreta FP, Perez RP, Johnson SW, Brennan JM, Rogatko A, Nash S, McAleer C, Hamilton TC, Roby D, Young RC, Ozols RF, Odwyer PJ. Phase-I and Pharmacokinetic Study of Ormaplatin (Tetraplatin, Nsc-363812) Administered on a Day-1 and Day-8 Schedule. Cancer Research. 1994 Feb;54(3):709-17.
Speicher LA, Barone LR, Chapman AE, Hudes GR, Laing N, Smith CD, Tew KD. P-Glycoprotein Binding and Modulation of the Multidrug- Resistant Phenotype by Estramustine. Journal of the National Cancer Institute. 1994 May 04;86(9):688-94.
Johnson SW, Ozols RF, Hamilton TC. Mechanisms of Drug-Resistance in Ovarian-Cancer. Cancer. 1993 Jan 15;71(2):644-9.
Perez RP, Hamilton TC, Ozols RF, Young RC. Mechanisms and Modulation of Resistance to Chemotherapy in Ovarian-Cancer. Cancer. 1993 Feb 15;71(4):1571-80.
Hamilton TC. Ovarian-Cancer 1. Biology. Current Problems in Cancer. 1992 Jan;16(1):5-57.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term carcinoma cell-lines

Last updated on Thursday, April 02, 2020